Category
Healthcare
7 articles
Healthcarebiz.heraldcorp.com
Celltrion Launches Three New Biosimilars in Brazil
Healthcarekoreaherald.com
Celltrion Unveils Promising Results for Four-Target Obesity Drug
Healthcarebiz.chosun.com
Celltrion Expands Brazil Portfolio with Autoimmune and Bone Therapies
Healthcaremt.co.kr
Samsung Biologics Achieves Top ESG Rating, Ranking 4th Globally
Healthcarevir.com.vn
Samsung Biologics Secures Top ESG Rating From Morningstar Sustainalytics
Healthcarefinance.yahoo.com
Samsung Biologics Achieves 'Negligible Risk' Rating in ESG Assessment
Healthcaremsn.com
Samsung Biologics Secures $323M Contract Amid Biosecure Act Changes
Samsung Biologics has landed a $323 million contract for biologics manufacturing, leveraging the US Biosecure Act.